株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

日本の分子診断市場

2017 Japan Molecular Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

発行 Venture Planning Group 商品コード 224812
出版日 ページ情報 英文 1126 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.44円で換算しております。

Local License: 同一事業所内

Back to Top
日本の分子診断市場 2017 Japan Molecular Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
出版日: ページ情報: 英文 1126 Pages
概要

当レポートでは、日本における分子診断市場の最新動向と将来展望について分析し、診断技術の研究開発の最新動向、世界市場の概況、日本市場の基本構造・動向、今後10年間の動向予測、市場拡大のための戦略と課題、主要企業プロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界市場と技術の概要

  • DNAシーケンシング
  • DNAおよびRNAプローブ技術
  • 検出技術
  • 医療装置のレビュー(全9種)
  • バイオチップ:遺伝子センサー・マイクロアレイ・ラブオンチップ
  • 薬理ゲノミクス
  • 主な用途
    • 微生物学/感染症
    • がん検査
    • 遺伝子疾患
    • 法医学的検査
    • 父子鑑定/HLA型判定
    • その他の用途
  • コスト分析
  • 競合・補足技術
  • 医療費還付の問題
  • 世界市場の概況
    • 事業環境
    • 市場構造
    • 市場規模・成長

日本市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模、成長、および主要サプライヤーの売上高・市場シェア

主な製品開発機会

  • 計測装置
  • 試薬キットおよび検査システム/パネル
  • コンピュータ・ソフトウェア・オートメーション
  • 補助製品

分散検査製品の設計基準

代替的な市場浸透戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散検査製品の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の優位性と限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業プロファイル

  • Abbott
  • Aclara
  • Affymetrix
  • Agilent
  • Ambion
  • Applied Biosystems
  • ARCA Biopharma
  • Beckman Coulter
  • BD
  • Biokit
  • bioMerieux
  • Biotest
  • Caliper
  • Cepheid
  • Chiron
  • Decode
  • Diadexus
  • Digene
  • 栄研化学
  • Enzo
  • Exact Sciences
  • 富士レビオ
  • Gen-Probe
  • Gene Tec
  • Illumina
  • Innogenetics
  • Kreatech
  • Li-Cor
  • Myriad Genetics
  • Nanogen
  • Orchid Biosciences
  • Qiagen
  • Roche
  • Sangtec
  • Sequenom
  • Seracare Life Science
  • Scienion
  • Sierra Diagnostics
  • 島津製作所
  • タカラバイオ
  • Tepnel Life Sciences
  • Tecan Group
  • Third Wave

付録

  • 付録1:分子診断用試薬・憲章キットを開発・市販している主な企業
  • 付録2:分子診断技術を開発している大学・研究センター
  • 付録3:用語集
  • 付録4:為替レート

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPMD24177
This new 1,126-page report from VPGMarketResearch.com contains 56 tables, and presents a comprehensive analysis of the Japanese molecular diagnostics market, including:
  • Major issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:

    - Infectious Diseases        - Forensic Testing
    -Cancer                                - Paternity Testing/HLA Typing
    - Genetic Diseases             - Others

    • Review of testing methodologies an instrumentation technologies.
    • Feature comparison of automated and semiautomated analyzers.
    • Sales and market shares of leading suppliers.
    • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
    • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
    • Alternative market penetration strategies.
    • Potential market entry barriers and risks.
    • Business planning issues and concerns.
    Contains 1,126 pages and 56 tables

    Table of Contents

    Introduction

    Worldwide Market And Technology Overview

    • A. DNA Sequencing
      • 1. Introduction
      • 2. Sequencing Methods
      • 3. Autoradiography
      • 4. The Human Genome Project
      • 5. Sequencing Automation
      • 6. Image Scanners
      • 7. Fluorescent Detection
      • 8. Gene Profiling
      • 9. Gene Expression
      • 10. Polymorphism Screening
      • 11. Protein Interaction Networks
    • B. DNA And RNA Probe Technology
      • 1. Basic Principles
      • 2. Probe Preparation
      • 3. The DNA Probe Test
        • a. Sample Preparation
        • b. Hybridization
        • c. Separation
        • d. Detection/Measurement
      • 4. Test Formats
        • a. Filter Hybridization
        • b. Southern Blot
        • c. Northern Blot
        • d. In Situ Hybridization
        • e. Others
      • 5. Labeling Techniques
      • 6. Amplification Methods
        • Polymerase Chain Reaction
          • Temperature Cyclers
          • PCR Variations
            • Immuno-PCR
            • QC-PCR
            • DAP-PCR
        • Strand Displacement Activation
        • TMA
        • Ligase Chain Reaction
        • Branched DNA
          • Hybridization Protection Assay
        • Nucleic-Acid Sequence-Based Amplification
        • Self-Sustained Sequence Replicase
        • Others
          • Ampliprobe
          • CAR
          • CAS
          • CPT
          • Dendritic Polymer Technology
          • ISO-CR
          • LAT
          • Probe Networks
          • RAMP
          • Repair Chain Reaction
          • Rolling Circles
          • Sequence Independent Gene Amplification
          • Sequence Initiation Reaction
          • SISPA
          • Solid Phase Amplification
    • C. Detection Technologies
      • 1. Radioactive Methods
        • a. Overview
        • b. Major Isotopes
          • P-32
          • S-35
          • H-3
          • I-125
      • 2. Non-Isotopic Methods
        • a. Enzymatic Labels
        • b. Chemical Labeling
          • Indirect Chemical Labeling
          • Direct Chemical Labeling
        • c. Fluorescence
        • d. Chemiluminescence
        • e. Electrical Conductivity
    • D. Instrumentation Review
      • 1. Abbott LCx
      • 2. Beckman Coulter/Biomek FK
      • 3. Becton Dickinson SDA
      • 4. Bio-Rad GeneScope
      • 5. Gen-Probe Tigris
      • 6. Roche Cobas Amplicor
      • 7. Tecan LS Series
    • E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
      • Liquid Transportation and Mixing
      • Separation
      • Reaction
      • Detection
    • F. Pharmacogenomics
    • G. Major Applications
      • 1. Microbiology/Infectious Diseases
        • a. Overview
        • b. Major Infectious Diseases
          • AIDS
            • Structure and Composition
            • Classification
            • AIDS Origins
            • Animal Lentivirus Systems
            • Virus Receptors
            • HIV Infections in Humans
              • Pathogenesis and Pathology
            • CD4T Lymphocytes and Memory Cells
            • Monocytes and Macrophages
            • Lymphoid Organs
            • Neural Cells
            • Viral Coinfections
              • Clinical Findings
            • Plasma Viral Load
            • Pediatric AIDS
              • Neurologic Disease
              • Opportunistic Infections
              • Cancer
            • Immunity
              • Virus Isolation
              • Serology
              • Viral Nucleic Acid/Antigen Detection
            • Epidemiology
              • Worldwide Spread of AIDS
              • United States
              • Routes of Transmission
            • DNA Probes
              • Overview
              • Quantitative PCR
              • In Situ PCR
              • Needed Improvements
            • Viral Load/Drug Resistance Testing
            • Genotype and Phenotype Testing
            • Blood Banking Considerations
              • Adenovirus
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
            • Adeno-Associated Viruses (AAV)
              • Anthrax/Bacillus Anthracis
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Babesiosis
            • Background
              • BEA and Other Bartonella Diseases
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Chagas Disease
            • Background
              • Campylobacter
            • Background
            • Diagnostic Tests
              • Culture Identification
            • Vaccines and Drugs
              • Chlamydia
            • Background
              • Chlamydia psittaci
              • Chlmaydia pneumoniae
              • Chlamydia trachomatis
            • Diagnostic Tests
            • Vaccines and Drugs
              • Creutzfeldt-Jakob's Disease
            • Background
            • Blood Transmission
            • Diagnostic Tests
            • Major Commercial and Academic Players
              • Bayer
              • Disease Sciences/Bio Tec Global
              • Imperial College School of Medicine
              • Ortho-Clinical Diagnostics
              • Pall
              • ProMetic Life Sciences
              • Proteome Sciences/Idexx
              • Q-One Biotech
              • Serono
              • U.S. Agricultural Research Service
            • Drugs
            • Vaccines
              • Cytomegalovirus
            • Background
              • Chorioretinitis
              • Gastrointestinal
              • Central Nervous System Disease
            • Diagnostic Tests
            • Vaccines and Drugs
              • Ebola Virus
            • Background
              • Epidemiology
              • Clinical Syndromes
            • Diagnostic Tests
            • Vaccines and Drugs
              • EchoVirus
            • Background
              • Acute Aseptic Meningitisis
              • Encephalitis
              • Exanthems
              • Respiratory Disease
              • Myopericarditis
              • Neonatal Infections
            • Diagnostic Tests
            • Vaccines and Drugs
              • Encephalitis
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Enteroviruses
            • Background
            • Diagnostic Tests
              • Viral Isolation and Identification
              • Antibody Tests
            • Vaccines and Drugs
              • Epstein-Barr Virus
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
          • Gonorrhea
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Hepatitis
            • Hepatitis A
            • Hepatitis B
              • Structure and Composition
              • Replication
            • Hepatitis C
            • Hepatitis D (Delta)
            • Hepatitis E
            • Hepatitis G
            • Hepatitis Infections Pathology
            • Clinical Findings
            • Laboratory Tests
              • Hepatitis A
              • Hepatitis B
              • Hepatitis C
              • Hepatitis D
              • Hepatitis E
            • Virus-Host Immune Reactions
            • Epidemiology
              • Hepatitis A
              • Hepatitis B
              • Hepatitis C
              • Hepatitis D (Delta)
            • Vaccines and Drugs
              • Herpes Simplex Virus
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Legionella
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Lyme Disease
            • Background
              • Clinical Description
              • Clinical Case Definition
              • Laboratory Criteria for Diagnosis
              • Case Classification
            • Diagnostic Tests
            • Vaccines and Drugs
              • Malaria
              • Mycoplasma
            • Background
              • Ureaplasma Urealyticum & Mycoplasma Hominis
            • Diagnostic Tests
            • Vaccines and Drugs
              • Papillomaviruses/HPV
            • Background
              • HPV in Cancer
              • Cervical Neoplasm
            • Diagnostic Tests
            • Vaccines and Drugs
              • Prevention
              • Parvovirus B19
            • Background
              • Microbiology
              • Epidemiology
              • Clinical Syndromes
              • Erythema Infectiosum (Slapped Cheek)
              • Adult Polyarthropathy
              • Transient Aplastic Crisis
              • Transient Pancytopenia
              • Red Cell Aplasia in Immunocompromised
              • Perinatal Infections
            • Diagnostic Test
            • Vaccines and Drugs
              • Pneumonia
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Polyomaviruses
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Salmonellosis
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Shigellosis
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Streptococci
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Group A Streptococci
              • Group B Streptococci
              • Toxoplasmosis
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
              • Tuberculosis
            • Background
            • Diagnostic Tests
              • Microscopic Characteristics
              • Cultural Characteristics
              • Skin Tests
              • MDRTB
            • Vaccines and Drugs
              • West Nile Virus
            • Background
              • Clinical Syndromes
            • Diagnostic Tests
            • Vaccines and Drugs
              • Yersinia
            • Background
            • Diagnostic Tests
            • Vaccines and Drugs
        • c. Antibiotic Susceptibility
      • 2. Cancer Testing
        • a. Overview
        • b. Major Cancer Types
          • Prostate
          • Lung
          • Colon and Rectum
          • Breast
          • Skin
          • Uterine
          • Leukemia
          • Oral
        • c. Oncogenes
          • Abl/abl-bcr
          • AIB1
          • BCL-2
          • BRCA1
          • CD44
          • C-fos
          • C-myb
          • C-myc
          • CYP17
          • Erb-B
          • HPC1
          • N-myc
          • P40
          • P51
          • P53
          • PIK3CA
          • PTI-1
          • Ras
          • Reg
          • Sis
          • Src
      • 3. Genetic Diseases
        • a. Overview
        • b. Nucleic Acid Amplification
        • c. Chromosome Imaging
        • d. Genomics Technologies
        • e. Proteomics Technologies
        • f. Current Pharmacogenomic Tests
        • g. Future Pharmacogenomic Testing
        • h. Major Diseases
          • Achondroplasia
          • Autosomal Dominant Polycystic Kidney Disease
          • Cancer
          • Cosmetogenomics
          • Cystic Fibrosis
          • Down's Syndrome
          • Duchenne and Becker Muscular Dystrophy
          • Factor V (Leiden)
          • Factor IX Deficiency
          • Fragile X Syndrome
          • Heart Disease
          • Hemochomatosis
          • Hemophilia
          • Huntington's Disease
          • Maternal-Fetal Incompatibility
          • Multiple Endocrine Neoplasia
          • Phenylketonuria (PKU)
          • Polycystic Kidney Disease (PKD)
          • Prenatal Screening
          • Retinitis Pigmentosa
          • Retinoblastoma
          • Sickle Cell Anemia
          • Spinal Muscular Atrophy
          • Vitamin B12 Metabolism
        • i. Social Issues and Concerns
      • 4. Forensic Testing
        • a. Overview
        • b. Multilocus and Single Locus Probes
          • Multilocus Probes
          • Single Locus Probes
          • PCR and RFLP
        • c. The FBI
        • d. DNA Profile Data Banks
          • U.S.A.
          • U.K.
        • e. Judicial Implementation
        • f. Major Crime Categories
        • g. Factors Contributing to the DNA Probe Market Expansion
          • Technology Availability
          • Use of Hair as Evidence
        • h. Wildlife Forensics
      • 5. Paternity Testing/HLA Typing
      • 6. Other Applications
        • a. Disease Susceptibility Testing
        • b. Cardiovascular Diseases
        • c. Diabetes
        • d. Alzheimer's Disease
        • e. Periodontal Disease
        • f. Plasma Purification
        • g. Organ Transplantation
        • h. Water Contamination
        • i. Other
    • H. Competing/complementing Technologies
      • 1. Monoclonal Antibodies/Immunoassays
      • 2. RNA Probes
      • 3. Two-Dimensional Electrophoresis
      • 4. Flow Cytometry

    Japan

    • A. Executive Summary
    • B. Business Environment
    • C. Market Structure
    • D. Market Size, Growth And Major Suppliers' Sales And Market Shares

    Major Product Development Opportunities

    • A. Instrumentation
    • B. Reagent Kits and Test Systems/panels
    • C. Computers, Software and Automation
    • D. Auxiliary Products

    Design Criteria For Decentralized Testing Products

    Alternative Market Penetration Strategies

    • A. Internal Development
    • B. Collaborative Arrangements
    • C. University Contracts
    • D. Distribution Strategies For Decentralized Testing Markets
      • 1. Marketing Approaches
      • 2. Product Complexity
      • 3. Customer Preference
      • 4. Established Suppliers
      • 5. Emerging Suppliers
      • 6. Major Types Of Distributors
      • 7. Market Segmentation

    Potential Market Entry Barriers And Risks

    • A. Market Maturity
    • B. Cost Containment
    • C. Competition
    • D. Technological Edge And Limitations
    • E. Patent Protection
    • F. Regulatory Constraints
    • G. Decentralized Testing Market Challenges

    Competitive Profiles

    • Abbott
    • Affymetrix
    • Agilent
    • Applied Gene Technologies
    • Arca
    • Beckman Coulter/Danaher
    • Becton Dickinson
    • Biokit
    • BioMerieux
    • Bio-Rad
    • Biotest
    • Caliper
    • Cepheid
    • Decode
    • Diadexus
    • Eiken
    • Enzo
    • Exact Sciences
    • Fujirebio
    • Gen-Probe
    • Hologic
    • Illumina
    • Innogenetics/Solvay
    • Kreatech
    • Li-Cor Biosciences
    • Life Technologies
    • Monogram Biosciences
    • Myriad Genetics
    • Nanogen/Elitech
    • Novartis
    • Orchid CellMark
    • Ortho-Clinical Diagnostics
    • Proteome Sciences
    • Qiagen
    • Roche
    • Scienion
    • Sequenom
    • Shimadzu
    • Siemens
    • Sierra Molecular
    • Takara Bio
    • Tecan Group

    Appendixes

    • Appendix I: Major Universities and Research Centers Developing Molecular Diagnostic Technology
    • Appendix II: Glossary of Terms
    • Appendix III: Currency Exchange Rates

    List of Tables

    • Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
    • Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
    • Oncogenes Potential Application in Cancer Diagnosis
    • Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
    • Major Companies Developing or Marketing Molecular Diagnostic Test For Genetic Diseases
    • Summary Table Japan, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
    • Japan, Laboratories Performing DNA Sequencing by Market Segment
    • Japan, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
    • Japan, Molecular Diagnostics Test Volume Forecast By Major Application
    • Japan, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
    • Japan, Infectious Disease Screening NAT Volume Forecast
    • Japan, Molecular Diagnostics Market Forecast By Major Application
    • Japan, Infectious Disease Screening Nat Reagent Market Forecast by Test
    • Japan, Molecular Diagnostics Market By Major Supplier
    • Japan, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Back to Top